secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inogen Inc (INGN)
CIK:        0001294133
Form:       8-K
Filed at:   2026-03-30T23:59:59+00:00
Accession:  0001193125-26-131855
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inogen names Jason Richardson CFO, appoints CMO and VP Sales; reaffirms 2026 guidance
--------------------------------------------------------------------------------

- Jason Richardson appointed CFO effective April 6, 2026; previously CFO of Baxter's Health System & Technologies segment.
- Michael Bourque steps down as CFO on April 6, remains Senior Advisor through June 30, 2026.
- Dominic Hulton appointed CMO effective April 1, 2026; previously VP International Marketing at Insulet.
- Corey Moritz appointed VP U.S. Business to Business Sales, started March 9; formerly CCO at Rhythm Healthcare.
- Company reaffirms Q1 and full year 2026 financial outlook provided on February 24, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1294133/000119312526131855/0001193125-26-131855-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1294133/000119312526131855/ingn-20260324.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-131855

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer